• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

CTMS Provider Velos Joins WCG

Share:

January 28, 2019

WCG acquires leading provider of eResearch solutions for the comprehensive, automated management of institutional clinical research

The WIRB-Copernicus Group®’s Clinical Services Division has acquired the Velos eResearch business line. Velos is a leading provider of clinical trial management solutions that increase the productivity and efficiency of clinical research. Velos links the administrative, financial, and regulatory elements of clinical research on a single, adaptable, easy-to-use technology platform making the execution of research more organized, more manageable and more profitable for institutions.

“We are pleased to welcome Velos to the WCG family,” said Donald A. Deieso, PhD, Executive Chairman and CEO of WCG. “WCG is privileged to serve more than 2,800 institutions, and we are thrilled to empower them with technology solutions that will increase the efficiency of their research programs.”

WCG partners with 93% of the institutions – and 90% of the academic medical centers – that conduct research in the United States. WCG helps institutions accommodate the changes which are occurring in the rapidly evolving drug development landscape by providing solutions that increase the efficiency and profitability of their research, accelerate patient enrollment and position them to attract increased industry funding.

“Our clients are recognized for their academic and clinical research excellence and scientific achievement,” said John S. McIlwain, MBA, Co-founder and CEO of Velos. “They are a critical part of the clinical research ecosystem. It is our mission to break down the silos and administrative barriers slowing their progress and limiting their growth, to enable them to accelerate breakthroughs in clinical care.”

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

An Internet platform solution, Velos eResearch simplifies the management of institutional research by linking study status, patient enrollment, calendars, budgets, billing, and electronic data capture. By centralizing the management of research activities – and the collection of research-related information – on a single electronic platform, Velos increases the efficiency, transparency and accessibility of institutional research.

Like WCG’s previous acquisitions, Velos will operate independently and retain its headquarters in Fremont, CA. WCG will support Velos with access to capital, expertise and corporate operational support.

Date: January 28, 2019

Source: Market Watch

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Liva Healthcare and Amgen Partner to Improve Access to Cardiac RehabilitationLiva Healthcare and Amgen Partner to Improve Access to Cardiac Rehabilitation
  • India’s Bioeconomy Surge Towards $300 BillionIndia’s Bioeconomy Surge Towards $300 Billion
  • SAS & Duke Health Announce AI Partnership.SAS & Duke Health Announce AI Partnership.
  • Merck Leans Into Immunology with $10.8B Prometheus BuyMerck Leans Into Immunology with $10.8B Prometheus Buy
  • Amazon Choice Integrates with One Drop for Diabetes and Hypertension ManagementAmazon Choice Integrates with One Drop for Diabetes and Hypertension Management
  • UnitedHealthcare Awards $11.1M in Grants to Expand Care AccessUnitedHealthcare Awards $11.1M in Grants to Expand Care Access
  • Lyra Therapeutics Completes $30 Million Series C FinancingLyra Therapeutics Completes $30 Million Series C Financing
  • Quellis Biosciences Inc. Announces $17 Million Series a FinancingQuellis Biosciences Inc. Announces $17 Million Series a Financing

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications